
The article outlines two options strategies for Merck & Co Inc (MRK) to enhance yield or optimize entry/exit points. Selling cash-secured $80 puts offers a 9.18% annualized return if expiring worthless, effectively lowering the acquisition cost to $75.05 for interested buyers, with a 61% chance of not being assigned. Alternatively, selling $85 covered calls provides an 11.45% annualized premium yield if expiring worthless, or a 10.16% total return if called away by April 2026, with a 48% chance of retaining shares and premium. These strategies demonstrate how options can be utilized to generate income or achieve favorable stock entry/exit prices on MRK, leveraging premium collection against defined risk parameters.
The provided text details two specific options strategies for Merck & Co Inc (MRK) stock, which is currently trading at $82.97 per share. The first strategy involves selling a cash-secured put at an $80.00 strike price, which would lower the potential acquisition cost to $75.05 after collecting a $4.95 premium. This out-of-the-money put has a 61% statistical probability of expiring worthless, which would result in a 6.19% return on the cash commitment, equivalent to a 9.18% annualized yield. The second strategy is for existing shareholders: selling a covered call at an $85.00 strike for a $6.40 premium. This would cap the total return at 10.16% if the stock is called away by the April 2026 expiration. There is a 48% chance this call expires worthless, in which case the investor keeps the premium, representing an 11.45% annualized yield boost. The analysis highlights a slight elevation in implied volatility (28% for the put, 30% for the call) compared to the actual trailing twelve-month volatility of 27%, suggesting option premiums may be slightly rich relative to recent historical price movements.
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request a DemoOverall Sentiment
neutral
Sentiment Score
0.00
Ticker Sentiment